Swiss global healthcare company Roche is reportedly considering offloading its blood glucose meter business.
According to Reuters, the drugmaker is exploring the sale of its diabetes device unit due to increased competition in the market and reimbursement pressure.
Sources close to the company told the news agency that talks about a potential sale of the business are still in their early stages. They did not disclose how much the Roche blood glucose meter unit was worth but stressed that a deal for business may not materialise.
In 2012, Germany’s biggest drugmaker Bayer AG tried to sell its blood glucose meter business for around $1.5 billion, but was forced to pull the plug on the sale early this year after failing to generate sufficient buyer interest.
All Roche diabetes care products are sold under the brand Accu-Chek . The company’s portfolio includes a range of blood sugar testing devices (glucose meters), which measure levels of sugar in the blood, and insulin pumps.
Roche considering exit from blood glucose meter market
Thu, 16 May 2013
Your comments may be moderated. Please report any spam, illegal, offensive or libellous posts.
Also related to this storyEffects of diabetes
Newly diagnosed with diabetes
Blood glucose and diabetes care
Blood glucose meters
Blood glucose meters guide
Accu-Chek glucose meters
Diabetic insurance and finance
Blood glucose testing
FreeStyle InsuLinx blood glucose meters recalled in the US
LifeScan announces global recall of blood glucose meters
FDA gives clearance to Bluetooth blood glucose meter
Innovative new blood glucose meter launched
Diabetes blood glucose meters warning
Lifescan warns Diabetes Sufferers Worldwide of Potential Problem with Its Blood Glucose Meters